Recent progress in antiviral chemotherapy for respiratory syncytial virus infections

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.2, 2000-02, pp. : 221-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Respiratory syncytial virus antiviral agents

By Prince G.A.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 753-762

Informa Healthcare

Access to resources Recommend Favorite

An update on respiratory syncytial virus antiviral agents

By Prince G.A.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 297-308

Informa Healthcare

Access to resources Recommend Favorite

Epidemiological Aspects of Respiratory Syncytial Virus (RSV) Infections in Italy: a National Survey

By Alvaro G Zuccotti GV

The Journal of International Medical Research, Vol. 28, Iss. 5, 2000-09 ,pp. : 207-213

Field House Publishing

Access to resources Recommend Favorite

Recent developments in the treatment and prevention of respiratory syncytial virus infection

By Krilov Leonard R

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 3, 2002-03 ,pp. : 441-449

Informa Healthcare

Access to resources Recommend Favorite

The development of antiviral therapy and vaccines against respiratory syncytial virus and human parainfluenza virus type 3

By A J.E.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite